| Literature DB >> 31053967 |
Magdalena Sosna1,2,3, Grażyna Tacikowska2,3, Katarzyna Pietrasik2,3, Henryk Skarżyński1,3, Artur Lorens4,3, Piotr H Skarżyński5,6,7,8.
Abstract
PURPOSE: Although the cochlear implantation procedure does not interfere with vestibular structures directly, both the vestibulum and the cochlea share the same inner ear fluid space, and this fluid may be responsible for transferring possibly damaging forces from one to the other. The purpose of the study is to assess postoperative vestibular function after partial deafness treatment-electro-acoustic stimulation (PDT-EAS) cochlear implantation.Entities:
Keywords: Atraumatic; Balance; Cochlear implantation; Electro-acoustic stimulation; Partial deafness treatment; Vestibule
Mesh:
Year: 2019 PMID: 31053967 PMCID: PMC6581932 DOI: 10.1007/s00405-019-05425-5
Source DB: PubMed Journal: Eur Arch Otorhinolaryngol ISSN: 0937-4477 Impact factor: 2.503
Fig. 1Four broad categories of partial hearing loss and how each is suited to four different types of partial deafness treatment
Etiology of deafness
| Etiology of deafness | Participant number |
|---|---|
| Sudden deafness | 9 |
| Unknown | 27 |
| Viral infection | 3 |
| Ototoxic medication | 5 |
| Postinflammatory | 3 |
| Acoustic trauma | 1 |
| Head trauma | 2 |
| Genetic | 1 |
| Meniere’s disease | 1 |
| Meningitis, cholesteatoma | 1 |
| TORCH | 1 |
| Otosclerosis | 1 |
Different types of inserted electrodes
| Electrode | Participant number |
|---|---|
| Med-El Sonata Medium | 3 |
| Med-El Concerto Medium | 1 |
| Med-El Sonata Flex 28 | 16 |
| Med-El Concerto Flex 28 | 4 |
| Med-El Synchrony Flex 28 | 2 |
| Med-El Sonata Flex 24 | 9 |
| Med-El Concerto Flex 24 | 3 |
| Med-El Synchrony Flex 24 | 2 |
Advanced Bionics Hi-Res 90k Advantage Mid-scala | 3 |
Cochlear Nucleus CI422 Slim straight electrode | 1 |
Cochlear Nucleus CI522 Slim straight electrode | 2 |
| Med-El Sonata Flex soft | 5 |
| Med-El Concerto Flex soft | 2 |
| Med-El Sonata Compressed | 1 |
| Med-El Sonata Form 24 | 1 |
Comparison of the groups with and without preserved vestibular responses after PDT–EAS cochlear implantation
| => | cVEMP | oVEMP | Caloric test | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Preserved | Damaged | Statistical significance | Preserved | Damaged | Statistical significance | Preserved | Damaged | Statistical significance | |
| 32/28 (84.21%) | 6/38 (15.79%) | 18/22 (80.96%) | 4/22 (19.04%) | 16/19 (84.21%) | 16/19 (84.21%) | ||||
| Age | 33.29 ( ± 16.66) | 55.93 ( ± 11.09) | 33.49 (± 15.72) | 51.35 (± 11.74) | 44.12 (± 22.14) | 58.72 (± 0.08) | |||
| Sex (female:male ratio) | 16:16 | 5:1 | 8:9 | 3:1 | 7:9 | 3:0 | |||
| Duration of hearing loss | 16.76 (± 13.08) | 18.96 (± 11.57) | 22.05 (± 15.00) | 17.85 (± 16.32) | 22.87 (± 13.78) | 31.06 (± 26.90) | |||
The prevalence of vestibular damage in the round window approach [15, 17–23]
| Loss of cVEMP response | Loss of oVEMP response/SVV | Reduction of caloric response | Gain reduction in vHIT | Degree of hearing loss | Electrode | Time of examination (after cochlear implantation procedure) | |
|---|---|---|---|---|---|---|---|
| Chen et al. [ | 41.67% (10/24) | 36.84% (7/19) | 93.10% (27/29)a | – | Severe to profound | Not mentioned | 4 weeks |
| Nordfalk et al. [ | 46.15% (12/26) | 25.92% (7/27)b | 36.36% (8/22)c | – | Low-frequency residual hearing ≤ 70dBHL 125Hz, 250Hz ≤ 90dBHL 500Hz | Flex 24, Flex 28, Flex soft | 6–8 weeks |
| Meli et al. [ | 76.47% (13/17) | – | 12.00% (3/25)d | – | Severe to profound | CI24RE, Med-el Concerto (electrode not given), Mid-scala | 2 months |
| Robard et al. [ | 54.54% (12/22)e | – | 72.40% (21/29)f | – | Not given | Contour advance, Hybrid L24, CI422 | 5 months |
| Louza et al. [ | 62.00% (18/29) | – | 27.00% (8/30)g | – | Not given | CI24 RECA, CI24 REST, Flex 28, Flex soft, Standard | 4–6 weeks |
| Tsukada et al. [ | 0.00% (0/11) 9.00% (1/11)h | – | 0.00% (0/11) | – | Low-frequency residual hearing ≤ 65dB HL 125,250, 500Hz ≥ 80dB HL 2kHz ≥ 85dB HL > 4kHz | Flex 24 | Minimal 4 weeks |
| Rah et al. [ | – | – | 0.00% (0/9) | – | Severe to profound | Not mentioned | 12 months |
| Dagkiran et al. [ | 11.90% (5/42) | 4.70% (2/42) | – | 2,30% (1/42)i | Severe to profound | Medium, slim straight | 3 months |
cVEMP cervical myogenic vestibular potential, oVEMP ocular myogenic vestibular potential, vHIT video head impulse test, UW unilateral weakness in caloric test, SVV subjective visual vertical, SPV slow phase velocity in caloric test
aSPV reduction
bPathological SVV (deviation more than 3°)
c>25% change in UW
dUW
eLoss or reduction of the amplitude in VEM
fUW or increasing in already existing deficit
gLoss or reduction of SCV
hReduction of VEMP amplitude
iApart from anterior semicircular canal